Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Guido Marcucci Monzr M Al Malki Vinod Pullarkat Ibrahim Aldoss Hoda Z Pourhassan |
| Publication date | September 10, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |